Literature DB >> 23019257

Forced vital capacity as a primary end point in idiopathic pulmonary fibrosis treatment trials: making a silk purse from a sow's ear.

Athol U Wells.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23019257     DOI: 10.1136/thoraxjnl-2012-202640

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  11 in total

1.  Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis.

Authors:  David J Lederer; Williamson Z Bradford; Elizabeth A Fagan; Ian Glaspole; Marilyn K Glassberg; Kenneth F Glasscock; David Kardatzke; Talmadge E King; Lisa H Lancaster; Steven D Nathan; Carlos A Pereira; Steven A Sahn; Jeffrey J Swigris; Paul W Noble
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

2.  Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

Authors:  Timothy S Blackwell; Andrew M Tager; Zea Borok; Bethany B Moore; David A Schwartz; Kevin J Anstrom; Ziv Bar-Joseph; Peter Bitterman; Michael R Blackburn; William Bradford; Kevin K Brown; Harold A Chapman; Harold R Collard; Gregory P Cosgrove; Robin Deterding; Ramona Doyle; Kevin R Flaherty; Christine Kim Garcia; James S Hagood; Craig A Henke; Erica Herzog; Cory M Hogaboam; Jeffrey C Horowitz; Talmadge E King; James E Loyd; William E Lawson; Clay B Marsh; Paul W Noble; Imre Noth; Dean Sheppard; Julie Olsson; Luis A Ortiz; Thomas G O'Riordan; Tim D Oury; Ganesh Raghu; Jesse Roman; Patricia J Sime; Thomas H Sisson; Daniel Tschumperlin; Shelia M Violette; Timothy E Weaver; Rebecca G Wells; Eric S White; Naftali Kaminski; Fernando J Martinez; Thomas A Wynn; Victor J Thannickal; Jerry P Eu
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

Review 3.  IPF clinical trial design and endpoints.

Authors:  Steven D Nathan; Keith C Meyer
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

Review 4.  Idiopathic Pulmonary Fibrosis: Treatment and Prognosis.

Authors:  Hajime Fujimoto; Tetsu Kobayashi; Arata Azuma
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-12-08

5.  Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacity.

Authors:  J Clukers; M Lanclus; B Mignot; C Van Holsbeke; J Roseman; S Porter; E Gorina; E Kouchakji; K E Lipson; W De Backer; J De Backer
Journal:  Respir Res       Date:  2018-11-06

6.  Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis.

Authors:  Joseph Jacob; Brian J Bartholmai; Coline H M van Moorsel; Srinivasan Rajagopalan; Anand Devaraj; Hendrik W van Es; Teng Moua; Frouke T van Beek; Ryan Clay; Marcel Veltkamp; Maria Kokosi; Angelo de Lauretis; Eoin P Judge; Teresa M Jacob; Tobias Peikert; Ronald Karwoski; Fabien Maldonado; Elisabetta Renzoni; Toby M Maher; Andre Altmann; Athol U Wells
Journal:  Eur Respir J       Date:  2019-09-30       Impact factor: 16.671

Review 7.  The present and future of cough counting tools.

Authors:  Jocelin Isabel Hall; Manuel Lozano; Luis Estrada-Petrocelli; Surinder Birring; Richard Turner
Journal:  J Thorac Dis       Date:  2020-09       Impact factor: 3.005

8.  The value of imaging and clinical outcomes in a phase II clinical trial of a lysophosphatidic acid receptor antagonist in idiopathic pulmonary fibrosis.

Authors:  Grace Hyun J Kim; Jonathan G Goldin; Wendy Hayes; Andrea Oh; Benjamin Soule; Shuyan Du
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

Review 9.  Molecular biomarkers in interstitial lung diseases.

Authors:  Angelo De Lauretis; Elisabetta A Renzoni
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

10.  Idiopathic pulmonary fibrosis: airway volume measurement identifies progressive disease on computed tomography scans.

Authors:  Thomas McLellan; Peter M George; Paul Ford; Jan De Backer; Cedric Van Holsbeke; Benjamin Mignot; Nicholas J Screaton; Alessandro Ruggiero; Muhunthan Thillai
Journal:  ERJ Open Res       Date:  2020-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.